Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy AmerisourceBergen Corporation stock
Learn how to easily invest in AmerisourceBergen Corporation stock.
AmerisourceBergen Corporation is a medical distribution business based in the US. AmerisourceBergen Corporation shares (ABC) are listed on the NYSE and all prices are listed in US Dollars. AmerisourceBergen Corporation employs 38,000 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in AmerisourceBergen Corporation
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ABC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- ABC shares summary
- Compare share dealing platforms
- Is ABC stock a buy or sell?
- Stock performance over time
- Is ABC suitable for ethical investing?
- Are ABC shares over-valued?
- AmerisourceBergen Corporation's financials
- How volatile are ABC shares?
- Does AmerisourceBergen Corporation pay a dividend?
- Have ABC shares ever split?
- Other common questions
AmerisourceBergen Corporation stock price (NYSE: ABC)Use our graph to track the performance of ABC stocks over time.
AmerisourceBergen Corporation shares at a glance
|Latest market close||$131.52|
|52-week range||$99.61 - $136.95|
|50-day moving average||$126.65|
|200-day moving average||$121.45|
|Wall St. target price||$150.92|
|Dividend yield||$1.76 (1.4%)|
|Earnings per share (TTM)||$7.39|
Buy AmerisourceBergen Corporation shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy AmerisourceBergen Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
AmerisourceBergen Corporation price performance over time
|1 week (2022-01-14)||-3.44%|
|1 month (2021-12-23)||1.54%|
|3 months (2021-10-20)||N/A|
|6 months (2021-07-23)||8.42%|
|1 year (2021-01-22)||22.05%|
|2 years (2020-01-24)||47.91%|
|3 years (2019-01-24)||67.12%|
|5 years (2017-01-24)||55.81%|
Is AmerisourceBergen Corporation stock undervalued or overvalued?
Valuing AmerisourceBergen Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AmerisourceBergen Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
AmerisourceBergen Corporation's P/E ratio
AmerisourceBergen Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, AmerisourceBergen Corporation shares trade at around 18x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
AmerisourceBergen Corporation's PEG ratio
AmerisourceBergen Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.4977. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into AmerisourceBergen Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
AmerisourceBergen Corporation's EBITDA
AmerisourceBergen Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.2 billion.
The EBITDA is a measure of a AmerisourceBergen Corporation's overall financial performance and is widely used to measure a its profitability.
AmerisourceBergen Corporation financials
|Revenue TTM||$214 billion|
|Operating margin TTM||1.25%|
|Gross profit TTM||$6.8 billion|
|Return on assets TTM||3.29%|
|Return on equity TTM||0%|
|Market capitalisation||$27.4 billion|
TTM: trailing 12 months
AmerisourceBergen Corporation's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like AmerisourceBergen Corporation.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
AmerisourceBergen Corporation's total ESG risk score
Total ESG risk: 8.4
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and AmerisourceBergen Corporation's overall score of 8.4 (as at 12/31/2018) is excellent – landing it in it in the 3rd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like AmerisourceBergen Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
AmerisourceBergen Corporation's environmental score
Environmental score: 1.11/100
AmerisourceBergen Corporation's social score
Social score: 5.01/100
AmerisourceBergen Corporation's governance score
Governance score: 1.78/100
AmerisourceBergen Corporation's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. AmerisourceBergen Corporation scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that AmerisourceBergen Corporation hasn't always managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||8.4|
|Total ESG percentile||2.5|
|Level of controversy||3|
AmerisourceBergen Corporation share dividends
Dividend payout ratio: 19.22% of net profits
Recently AmerisourceBergen Corporation has paid out, on average, around 19.22% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.4% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), AmerisourceBergen Corporation shareholders could enjoy a 1.4% return on their shares, in the form of dividend payments. In AmerisourceBergen Corporation's case, that would currently equate to about $1.76 per share.
While AmerisourceBergen Corporation's payout ratio might seem low, this can signify that AmerisourceBergen Corporation is investing more in its future growth.
AmerisourceBergen Corporation's most recent dividend payout was on 28 November 2021. The latest dividend was paid out to all shareholders who bought their shares by 11 November 2021 (the "ex-dividend date").
Have AmerisourceBergen Corporation's shares ever split?
AmerisourceBergen Corporation's shares were split on a 2:1 basis on 15 June 2009. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your AmerisourceBergen Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for AmerisourceBergen Corporation shares which in turn could have impacted AmerisourceBergen Corporation's share price.
AmerisourceBergen Corporation share price volatility
Over the last 12 months, AmerisourceBergen Corporation's shares have ranged in value from as little as $99.6054 up to $136.95. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while AmerisourceBergen Corporation's is 0.5073. This would suggest that AmerisourceBergen Corporation's shares are less volatile than average (for this exchange).
AmerisourceBergen Corporation overview
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania. .
AmerisourceBergen Corporation in the news
Earnings playbook: A complete guide to this week's reports, including the first of tech
Discrimination lawsuit filed against AmerisourceBergen by its former DEI chief is dismissed
7 Low Labor-Cost Stocks to Buy for Solid Margins in 2022
Frequently asked questionsWhat percentage of AmerisourceBergen Corporation is owned by insiders or institutions?
Currently 28.526% of AmerisourceBergen Corporation shares are held by insiders and 64.851% by institutions. How many people work for AmerisourceBergen Corporation?
Latest data suggests 38,000 work at AmerisourceBergen Corporation. When does the fiscal year end for AmerisourceBergen Corporation?
AmerisourceBergen Corporation's fiscal year ends in September. Where is AmerisourceBergen Corporation based?
AmerisourceBergen Corporation's address is: 1 West First Avenue, Conshohocken, PA, United States, 19428-1800 What is AmerisourceBergen Corporation's ISIN number?
AmerisourceBergen Corporation's international securities identification number is: US03073E1055 What is AmerisourceBergen Corporation's CUSIP number?
AmerisourceBergen Corporation's Committee on Uniform Securities Identification Procedures number is: 03071P102
More guides on Finder
How to order free at-home COVID tests today — but note, there’s a wait
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
Today’s top U.S. stocks: Las Vegas Sands (LVS ↑15.3%), Wynn Resorts Limited (WYNN ↑9.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.